Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs cyclopropofol vs remimazolam for PONV after laparoscopic cholecystectomy
ChiCTR2600126374Phase 4Recruiting
- Sponsor
- Xi'an Aerospace General Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative nausea and vomiting (PONV) comparing Group P (propofol), Group H (cyclopropofol) and Group R (remimazolam) (3 arms). Primary endpoint: Incidence of nausea and vomiting within 24 hours after surgery. Started Jun 2026; status: recruiting.
02
Drugs
propofolciprofolremimazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600126374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126374.